AN2 Therapeutics, Inc.
Pharmaceutical company · Menlo Park, California, United States · Nasdaq: ANTX
AN2 Therapeutics, Inc. is a pharmaceutical company headquartered in Menlo Park, California, United States. Its shares trade on Nasdaq under the ticker ANTX. It has reported private securities offerings to the US SEC, most recently $40 million sold in a notice filed in 2026.
AN2 Therapeutics at a glance
What does AN2 Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $40 million sold (2026).
Frequently asked questions about AN2 Therapeutics
Where is AN2 Therapeutics headquartered?
AN2 Therapeutics, Inc. is headquartered in Menlo Park, California, United States.
What does AN2 Therapeutics do?
AN2 Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is AN2 Therapeutics a public company?
Yes. AN2 Therapeutics, Inc. trades on Nasdaq under the ticker ANTX.
Similar companies
- Oruka Therapeutics, Inc.Menlo Park, California, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.